logo IST    

istituto nazionale per la ricerca sul cancro

Home Mappa del sito Cerca Informazioni al pubblico Clinica e Ricerca Intranet

Pubblicazioni Scientifiche 2003


Pubblicazioni 2003 Index Medicus

Riviste censite dal Science Citation Index (ed. 2002)

AAPRO M.-VAN WIJK F.-BOLIS G.-CHEVALLIER B.-VAN DER BURG M.-POVEDA A.-DE OLIVEIRA C.- TUMOLO S.-SCOTTO V.-PICCART M.-FRANCHI M.-ZANABONI F.-LACAVE A.-FONTANELLI R.-FAVALLI G.-ZOLA P.- GUASTALLA J.-ROSSO R.-MARTH C.-NOOIJ M.-PRESTI M.-SCARABELLI C.-SPLINTER T.-PLOCH E.-BEEX L.- TEN BOKKEL W.-FORNI M.-MELPIGNANO M.-BLAKE P.-KERBRAT P.-MENDIOLA C.-CERVANTES A.-GOUPIL A.-HARPER P.- MADRONAL C.-NAMER M.-SCARFONE G.-STOOT J.-TEODOROVIC I.-COENS C.-VERGOTE I.-VERMORKEN J.
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.
Ann. Oncol. 14:441/448, 2003
PubMed Abstract
AAPRO M.-VAN WIJK F.-VAN DER BURG M.-TEN BOKKEL W.-VERGOTE I.-GUASTALLA J.- ROSSO R.-KOBIERSKA A.-BEEX L.-NAMER M.-SPLINTER T.-VERMORKEN J.
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group.
Eur. J. Cancer 39:1141/1143, 2003
PubMed Abstract
AGOSTINELLI S.-ALLISON J.-AMAKO K.-APOSTOLAKIS J.-ARAUJO H.-ARCE P.-ASAI M.-AXEN D.-BANERJEE S.- BARRAND G.-BEHNER F.-BELLAGAMBA L.-BOUDREAU J.-BROGLIA L.-BRUNENGO A.-BURKHARDT H.-CHAUVIE S.- CHUMA J.-CHYTRACEK R.-COOPERMAN G.-COSMO G.-DEGTYARENKO P.-DELL'ACQUA A.-DEPAOLA G.-DIETRICH D.- ENAMI R.-FELICIELLO A.-FERGUSON C.-FESEFELDT H.-FOLGER G.-FOPPIANO F.-FORTI A.-GARELLI S.-GIANI S.- GIANNITRAPANI R.-GIBIN D.-GOMEZ J.-GONZALEZ I.-GRACIA G.-GREENIAUS G.-GREINER W.-GRICHINE V.- GROSSHEIM A.-GUATELLI S.-GUMPLINGER P.-HAMATSU R.-HASHIMOTO K.-HASUI H.-HEIKKINEN A.-HOWARD A.- IVANCHENKO V.-JOHNSON A.-JONES F.-KALLENBACH J.-KANAYA N.-KAWABATA M.-KAWABATA Y.-KAWAGUTI M.- KELNER S.-KENT P.-KIMURA A.-KODAMA T.-KOKOULIN R.-KOSSOV M.-KURASHIGE H.-LAMANNA E.-LAMPEN T.- LARA V.-LEFEBURE V.-LEI F.-LIENDL M.-LOCKMAN W.-LONGO F.-MAGNI S.-MAIRE M.-MEDERNACH E.-MINAMIMOTO K.- MORA P.-MORITA Y.-MURAKAMI K.-NAGAMATU M.-NARTALLO R.-NIEMINEN P.-NISHIMURA T.-OHTSUBO K.-OKAMURA M.- O'NEALE S.-OOHATA Y.-PAECH K.-PERL J.-PFEIFFER A.-PIA M.-RANJARD F.-RYBIN A.-SADILOV S.-DI SALVO E.- SANTIN G.-SASAKI T.-SAVVAS N.-SAWADA Y.-SCHERER S.-SEI S.-SIROTENKO V.-SMITH D.-STARKOV N.- STOECKER H.-SULKIMO J.-TAKAHATA M.-TANAKA S.-TCHERNIAEV E.-SAFAI E.-TROPEANO M.-TRUSCOTT P.-UNO H.- URBAN L.-URBAN P.-VERDERI M.-WALKDEN A.-WANDER W.-WEBER H.-WELLISCH J.-WENAUS T.-WILLIAMS D.- WRIGHT D.-YAMADA T.-YOSHIDA H.-ZSCHIESCHE D.
GEANT4, a simulation toolkit.
Nucl. Instrum. Meth. A 506:250/303, 2003
ALBERTI S.-PARODI S.
Signaling protein networks as targets of new antineoplastic drugs.
Int. J. Biol. Markers 18:57/61, 2003
PubMed Abstract
ALCALAY M.-MEANI N.-GELMETTI V.-FANTOZZI A.-FAGIOLI M.-ORLETH A.-RIGANELLI D.-SEBASTIANI C.- CAPPELLI E.-CASCIARI C.-SCIURPI M.-MARIANO A.-MINARDI S.-LUZI L.-MULLER H.-DI FIORE P.-FROSINA G.- PELICCI P.
Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair.
J. Clin. Invest. 112:1751/1761, 2003
PubMed Abstract
AMBROS I.-BENARD J.-BOAVIDA M.-BOWN N.-CARON H.-COMBARET V.-COUTURIER J.-DARNFORS C. -DELATTRE O.-FREEMAN J.-GAMBINI C.-GROSS N.-HATTINGER C.-LUEGMAYR A.-LUNEC J.-MARTINSSON T.- MAZZOCCO K.-NAVARRO S.-NOGUERA R.-O'NEILL S.-POTSCHGER U.-RUMPLER S.-SPELEMAN F.-TONINI G.P.- VALENT A.-VAN ROY N.-AMANN G.-DE BERNARDI B.-KOGNER P.-LADENSTEIN R.-MICHON J.-PEARSON A.-AMBROS P.
Quality assessment of genetic markers used for therapy stratification.
J. Clin. Oncol. 21:2077/2084, 2003
PubMed Abstract
ANDREYEV H.-BENAMOUZIG R.-BERANEK M.-CLARKE P.-CUNNINGHAM D.-NORMAN A.-GIARETTI W.- DE GOEIJ A.-IACOPETTA B.-JULLIAN E.-KRTOLICA K.-LEE J.-WANG S.-LEES N.-AL MULLA F.-MULLER O.- PAULY M.-PRICOLO V.-RUSSO A.-TROUNGOS C.-UROSEVIC N.-WARD R.
Mutant K/ras2 in serum. Letter.
Gut 52:915/916, 2003
PubMed Abstract
ARDIZZONI A.
Shorter is not better. Reply.
J. Clin. Oncol. 21:1648/1649, 2003
ARDIZZONI A.-LOPREVITE M.
RAS inhibitors.
Tumori 2(suppl):S17/S18, 2003
ARDIZZONI A.-MANEGOLD C.-DEBRUYNE C.-GAAFAR R.-BUCHHOLZ E.-SMIT E.-LIANES P.- TEN VELDE G.-BOSQUEE L.-LEGRAND C.-NEUMAIER C.-KING K.-GIACCONE G.
European Organization for Research and Treatment of Cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second line treatment of refractory and sensitive small cell lung cancer.
Clin. Cancer Res. 9:143/150, 2003
PubMed Abstract
ASTIGIANO S.-DAMONTE P.-BARBIERI O.
Inhibition of ductal morphogenesis in the mammary gland of WAP fgf4 transgenic mice.
Anat. Embryol. 206:471/478, 2003
PubMed Abstract
AUGUGLIARO R.-PAROLINI S.-CASTRICONI R.-MARCENARO E.-CANTONI C.-NANNI M.-MORETTA L.-MORETTA A.- BOTTINO C.
Selective cross talk among natural cytotoxicity receptors in human natural killer cells.
Eur. J. Immunol. 33:1235/1241, 2003
PubMed Abstract
BAAS P.-ARDIZZONI A.-GROSSI F.-NACKAERTS K.-NUMICO G.-VAN MARCK E.-VAN DE VIJVER M.-MONETTI F.- SMID M.-VAN ZANDWIJK N.-DEBRUYNE C.-LEGRAND C.-GIACCONE G.
The activity of raltitrexed (tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992).
Eur. J. Cancer 39:353/357, 2003
PubMed Abstract
BAEK S.-KIOUSSI C.-BRIATA P.-WANG D.-NGUYEN H.-OHGI K.-GLASS C.-WYNSHAW A.-ROSE D.-ROSENFELD M.
Regulated subset of G1 growth control genes in response to derepression by the Wnt pathway.
Proc. Natl. Acad. Sci. USA 100:3245/3250, 2003
PubMed Abstract
BALDINI E.-GARDIN G.-GIANNESSI P.-EVANGELISTA G.-RONCELLA M.-PROCHILO T.-COLLECCHI P.-ROSSO R.- LIONETTO R.-BRUZZI P.-MOSCA F.-CONTE P.
Accelerated versus standard cyclophosphamide, epirubicin and 5/fluorouracil or cyclophosphamide, methotrexate and 5/fluorouracil: a randomized phase III trial in locally advanced breast cancer.
Ann. Oncol. 14:227/232, 2003
PubMed Abstract
BARBERO S.-BONAVIA R.-BAJETTO A.-PORCILE C.-PIRANI P.-RAVETTI J.-ZONA G.-SPAZIANTE R.-FLORIO T.- SCHETTINI G.
Stromal cell derived factor 1 alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal regulated kinases 1/2 and Akt.
Cancer Res. 63:1969/1974, 2003
PubMed Abstract
BARBIERI F.-ALAMA A.-TASSO B.-BOIDO V.-BRUZZO C.-SPARATORE F.
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.
Invest. New Drugs 21:413/420, 2003
PubMed Abstract
BARBIERI F.-SPARATORE A.-ALAMA A.-NOVELLI F.-BRUZZO C.-SPARATORE F.
Novel sigma binding site ligands as inhibitors of cell proliferation in breast cancer.
Oncol. Res. 13:455/461, 2003
PubMed Abstract
BARBIERI O.-ASTIGIANO S.-MORINI M.-TAVELLA S.-SCHITO A.-CORSI A.-DI MARTINO D.-BIANCO P.- CANCEDDA R.-GAROFALO S.
Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation.
Am. J. Physiol. Cell Physiol. 285:C1504/C1512, 2003
PubMed Abstract
BARBIERO L.-BENUSSI L.-GHIDONI R.-ALBERICI A.-RUSSO C.-SCHETTINI G.-PAGANO S.-PARATI E.-MAZZOLI F. -NICOSIA F.-SIGNORINI S.-FEUDATARI E.-BINETTI G.
BACE/2 is overexpressed in Down's syndrome.
Exp. Neurol. 182:335/345, 2003
PubMed Abstract
BARBORO P.-D'ARRIGO C.-MORMINO M.-CORADEGHINI R.-PARODI S.-PATRONE E.-BALBI C.
An intranuclear frame for chromatin compartmentalization and higher order folding.
J. Cell. Biochem. 88:113/120, 2003
PubMed Abstract
BARRETT J.-VARDULAKI K.-CONLON C.-COOKE J.-DAZA P.-EVANS E.-HAWKEY P.-HERBRECHT R. -MARKS D.-MORALEDA J.-PARK G.-SENN S.-VISCOLI C.
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations.
Clin. Ther. 25:1295/1320, 2003
PubMed Abstract
BENASSO M.-PONZANELLI A.
I trattamenti chemioradianti nelle neoplasie del distretto cervico cefalico.
Tumori 2(suppl):S63/S64, 2003
BENASSO M.-LIONETTO R.-CORVO' R.-PONZANELLI A.-VITALE V.-ROSSO R.
Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation.
Eur. J. Cancer 39:1895/1898, 2003
PubMed Abstract
BENELLI R.-ALBINI A.-NOONAN D.
Neutrophils and angiogenesis: potential initiators of the angiogenic cascade.
Chem. Immunol. Allergy 83:167/181, 2003
BENELLI R.-MORINI M.-BRIGATI C.-NOONAN D.-ALBINI A.
Angiostatin inhibits extracellular HIV Tat induced inflammatory angiogenesis.
Int. J. Oncol. 22:87/91, 2003
PubMed Abstract
BENELLI R.-PEISSEL B.-MANENTI G.-GARIBOLDI M.-VANZETTO C.-ALBINI A.-DRAGANI T.
Allele specific patterns of the mouse parathyroid hormone related protein: influences on cell adhesion and migration.
Oncogene 22:7711/7715, 2003
PubMed Abstract
BENNETT J.-KAUFFMAN C.-WALSH T.-DE PAUW B.-DISMUKES W.-GALGIANI J.-GLAUSER M.-HERBRECHT R.-LEE J.- PAPPAS P.-POWERS J.-REX J.-VERWEIJ P.-VISCOLI C.
Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.
Clin. Infect. Dis. 36(suppl):123/127, 2003
PubMed Abstract
BENNETT J.-POWERS J.-DE PAUW B.-DISMUKES W.-GALGIANI J.-GLAUSER M.-HERBRECHT R.-KAUFFMAN C.-LEE J. -PAPPAS P.-REX J.-VERWEIJ P.-VISCOLI C.-WALSH T.
Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.
Clin. Infect. Dis. 36(suppl):113/116, 2003
PubMed Abstract
BENNETT J.-POWERS J.-WALSH T.-VISCOLI C.-DE PAUW B.-DISMUKES W.-GALGIANI J.-GLAUSER M.-HERBRECHT R. -KAUFFMAN C.-LEE J.-PAPPAS P.-REX J.-VERWEIJ P.
Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.
Clin. Infect. Dis. 36(suppl):117/122, 2003
PubMed Abstract
BERTARIO L.-RUSSO A.-SALA P.-VARESCO L.-GIAROLA M.-MONDINI P.-PIEROTTI M.-SPINELLI P.-RADICE P.
Multiple approach to the exploration of genotype phenotype correlations in familial adenomatous polyposis.
J. Clin. Oncol. 21:1698/1707, 2003
PubMed Abstract
BEVILACQUA A.-CERIANI M.-CANTI G.-ASNAGHI L.-GHERZI R.-BREWER G.-PAPUCCI L.-SCHIAVONE N.- CAPACCIOLI S.-NICOLIN A.
Bcl/2 protein is required for the adenine uridine rich element (ARE) dependent degradation of its own messenger.
J. Biol. Chem. 278:23451/23459, 2003
PubMed Abstract
BICOCCHI M.-PASINO M.-LANZA T.-BOTTINI F.-BOERI E.-MORI P.-MOLINARI A.-ROSANO C.-ACQUILA M.
Analysis of 18 novel mutations in the factor VIII gene.
Br. J. Haematol. 122:810/817, 2003
PubMed Abstract
BIANCHI G.-BANFI A.-MASTROGIACOMO M.-NOTARO R.-LUZZATTO L.-CANCEDDA R.-QUARTO R.
Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2.
Exp. Cell Res. 287:98/105, 2003
PubMed Abstract
BIGHIN C.-CATZEDDU T.-VENTURINI M.
HER2 inhibitors in the treatment of breast cancer patients.
Tumori 2(suppl):S21/S22, 2003
BIGHIN C.-CATZEDDU T.-VENTURINI M.
Linfonodi positivi. Parliamo di standard.
Tumori 2(suppl):S6/S8, 2003
BISACCHI D.-BENELLI R.-VANZETTO C.-FERRARI N.-TOSETTI F.-ALBINI A.
Anti angiogenesis and angioprevention: mechanisms, problems and perspectives.
Cancer Detect. Prev. 27:229/238, 2003
PubMed Abstract
BOCCARDO F.
Esiste una terapia adiuvante nell'early stage?
Tumori 2(suppl):S150, 2003
BOCCARDO F.-CIATTO S.-MARTORANA G.
Italian national consensus conference on prostate cancer screening (Florence, may 17, 2003). Final consensus document.
Int. J. Biol. Markers 18:238/240, 2003
PubMed Abstract
BOCCARDO F.-GUGLIELMINI P.
Ifosfamide in urologic cancer.
Oncology 65(suppl):67/72, 2003
PubMed Abstract
BOCCARDO F.-LUNARDI G.-PETTI A.-RUBAGOTTI A.
Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk.
Breast Cancer Res. Treat. 79:17/23, 2003
PubMed Abstract
BOCCARDO F.-RUBAGOTTI A.-CARMIGNANI G.-ROMAGNOLI A.-NICOLO' G.-BARBORO P.-PARODI S.-PATRONE E.- BALBI C.
Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer.
Prostate 55:259/264, 2003
PubMed Abstract
BOLOGNESI C.
Genotoxicity of pesticides: a review of human biomonitoring studies.
Mutat. Res. Rev. Mutat. 543:251/272, 2003
PubMed Abstract
BONALDI T.-TALAMO F.-SCAFFIDI P.-FERRERA D.-PORTO A.-BACHI A.-RUBARTELLI A.-AGRESTI A.-BIANCHI M.
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.
EMBO J. 22:5551/5560, 2003
PubMed Abstract
BONASSI S.-NERI M.-LANDO C.-CEPPI M.-LIN Y.-CHANG W.-HOLLAND N.-KIRSCH M.-ZEIGER E.-FENECH M.
Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus project.
Mutat. Res. Rev. Mutat. 543:155/166, 2003
PubMed Abstract
BONAVIA R.-BAJETTO A.-BARBERO S.-PIRANI P.-FLORIO T.-SCHETTINI G.
Chemokines and their receptors in the CNS: expression of CXCL12/SDF/1 and CXCR4 and their role in astrocyte proliferation.
Toxicol. Lett. 139:181/189, 2003
PubMed Abstract
BONELLI L.-ASTE H.-BOVO P.-CAVALLINI G.-FELDER M.-GUSMAROLI R.-MORANDINI E.-RAVELLI P.-BRIGLIA R.- LOMBARDO L.-DE MICHELI A.-PUGLIESE V.
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case control study in northern Italy.
Pancreas 27:143/149, 2003
PubMed Abstract
BORSI L.-BALZA E.-CARNEMOLLA B.-SASSI F.-CASTELLANI P.-BERNDT A.-KOSMEHL H.-BIRO A.-SIRI A.- ORECCHIA P.-GRASSI J.-NERI D.-ZARDI L.
Selective targeted delivery of TNF alpha to tumor blood vessels.
Blood 102:4384/4392, 2003
PubMed Abstract
BOTTINO C.-CASTRICONI R.-PENDE D.-RIVERA P.-NANNI M.-CARNEMOLLA B.-CANTONI C.-GRASSI J.- MARCENARO S.-REYMOND N.-VITALE M.-MORETTA L.-LOPEZ M.-MORETTA A.
Identification of PVR (CD155) and nectin/2 (CD112) as cell surface ligands for the human DNAM/1 (CD226) activating molecule.
J. Exp. Med. 198:557/567, 2003
PubMed Abstract
BRIATA P.-ILENGO C.-CORTE G.-MORONI C.-ROSENFELD M.-CHEN C.-GHERZI R.
The Wnt/beta catenin --> Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs.
Mol. Cell 12:1201/1211, 2003
PubMed Abstract
BORGHI R.-VENE' R.-ARENA G.-SCHUBERT D.-ALBINI A.-TOSETTI F.
Transient modulation of cytoplasmic and nuclear retinoid receptors expression in differentiating human teratocarcinoma NT2 cells.
J. Neurochem. 84:94/104, 2003
PubMed Abstract
BRIGATI C.-GIACCA M.-NOONAN D.-ALBINI A.
HIV Tat, its TARgets and the control of viral gene expression.
FEMS Microbiol. Lett. 220:57/65, 2003
PubMed Abstract
CAFIERO F.-GIPPONI M.-LIONETTO R.
Randomised clinical trial of adjuvant postoperative RT vs sequential postoperative RT plus 5/FU and levamisole in patients with stage II/III resectable rectal cancer: a final report.
J. Surg. Oncol. 83:140/146, 2003
PubMed Abstract
CAMPODONICO F.-MICHELAZZI A.-BENELLI R.-TONCINI C.
Simple method for in vitro bladder urothelium regeneration on a heterologous acellular matrix. Letter.
Pediatr. Surg. Int. 19:415/416, 2003
PubMed Abstract
CAMPODONICO F.-MICHELAZZI A.-OGNIO E.-FAVRE A.-CARMIGNANI G.
Patch urethroplasty using a fascia lata autograft in male rabbits.
Urol. Int. 71:242/245, 2003
PubMed Abstract
CANCEDDA R.-BIANCHI G.-DERUBEIS A.-QUARTO R.
Cell therapy for bone disease: a review of current status.
Stem Cells 21:610/619, 2003
PubMed Abstract
CANCEDDA R.-DOZIN B.-GIANNONI P.-QUARTO R.
Tissue engineering and cell therapy of cartilage and bone.
Matrix Biol. 22:81/91, 2003
PubMed Abstract
CANCEDDA R.-MASTROGIACOMO M.-BIANCHI G.-DERUBEIS A.-MURAGLIA A.-QUARTO R.
Bone marrow stromal cells and their use in regenerating bone.
Novartis Found. Symp. 249:133/147, 2003
PubMed Abstract
CANGEMI G.-MORANDI B.-D'AGOSTINO A.-PERI C.-CONTE R.-DAMONTE G.-FERLAZZO G.-BIASSONI R.-MELIOLI G.
IFN/alpha mediates the up regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome.
Int. Immunol. 15:1415/1421, 2003
PubMed Abstract
CANTONI C.-PONASSI M.-BIASSONI R.-CONTE R.-SPALLAROSSA A.-MORETTA A.-MORETTA L.-BOLOGNESI M.- BORDO D.
The three dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity.
Structure (Camb) 11:725/734, 2003
PubMed Abstract
CAPOCACCIA R.-GATTA G.-ROAZZI P.-CARRANI E.-SANTAQUILANI M.-DE ANGELIS R.-TAVILLA A.-EUROCARE Working Group-VERCELLI M.
The EUROCARE/3 database: methodology of data collection, standardisation, quality control and statistical analysis.
Ann. Oncol. 14(suppl):V14/V27, 2003
PubMed Abstract
CAPPELLI E.-D'OSUALDO A.-BOGLIOLO M.-KELLEY M.-FROSINA G.
Drosophila S3 ribosomal protein accelerates repair of 8/oxoguanine performed by human and mouse cell extracts.
Environ. Mol. Mutagen. 42:50/58, 2003
PubMed Abstract
CAPPELLI E.-D'OSUALDO A.-BOGLIOLO M.-XU Y.-KELLEY M.-FROSINA G.
Repair of 8 oxoguanine in mammalian cells expressing the Drosophila S3 ribosomal repair protein.
Teratog. Carcinog. Mutagen. 123(suppl):113/121, 2003
PubMed Abstract
CAPPUZZO F.-ARDIZZONI A.-SOTO H.-GRIDELLI C.-MAIONE P.-TISEO M.-CALANDRI C.-BARTOLINI S.-SANTORO A. -CRINO' L.
Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non small cell lung cancer (NSCLC).
Lung Cancer 41:227/231, 2003
PubMed Abstract
CASTAGNOLA E.-BONI L.-GIACCHINO M.-CESARO S.-DE SIO L.-GARAVENTA A.-ZANAZZO G.-BIDDAU P.-ROSSI M.- SCHETTINI F.-BRUZZI P.-VISCOLI C.
A multicenter, randomized, double blind placebo controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer.
Pediatr. Infect. Dis. J. 22:359/365, 2003
PubMed Abstract
CASTAGNOLA E.-MOLINARI A.-FRATINO G.-VISCOLI C.
Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary.
Br. J. Haematol. 121:233/239, 2003
PubMed Abstract
CASTRICONI R.-CANTONI C.-DELLA CHIESA M.-VITALE M.-MARCENARO E.-CONTE R.-BIASSONI R.-BOTTINO C.- MORETTA L.-MORETTA A.
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK mediated killing of dendritic cells.
Proc. Natl. Acad. Sci. USA 100:4120/4125, 2003
PubMed Abstract
CERRANO P.-JASANI B.-FILIBERTI R.-NERI M.-MERLO F.-DE FLORA S.-MUTTI L.-PUNTONI R.
Simian virus 40 and malignant mesothelioma.
Int. J. Oncol. 22:187/194, 2003
PubMed Abstract
CESARIO A.-GALETTA D.-RUSSO P.-MARGARITORA S.-GRANONE P.
The role of the surgeon in translational research. Letter.
Lancet 362:1082, 2003
PubMed Abstract
CHIORAZZI N.-FERRARINI M.
B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.
Annu. Rev. Immunol. 21:841/894, 2003
PubMed Abstract
CICCHETTI S.-SPINA B.-NICOLO' G.-SANTI P.L.
Trilucent breast implants five years' experience from an italian perspective.
Ann. Plast. Surg. 51:229/235, 2003
PubMed Abstract
COLEMAN M.-GATTA G.-VERDECCHIA A.-ESTEVE J.-SANT M.-STORM H.-ALLEMANI C.-CICCOLALLO L.- SANTAQUILANI M.-BERRINO F.-EUROCARE Working Group-VERCELLI M.
EUROCARE/3 summary: cancer survival in Europe at the end of the 20th century.
Ann. Oncol. 14(suppl):V128/V149, 2003
PubMed Abstract
COLOMBO M.-DONO M.-GAZZOLA P.-CHIORAZZI N.-MANCARDI G.-FERRARINI M.
Maintenance of B lymphocyte related clones in the cerebrospinal fluid of multiple sclerosis patients.
Eur. J. Immunol. 33:3433/3438, 2003
PubMed Abstract
COMETTA A.-KERN W.-DE BOCK R.-PAESMANS M.-VANDENBERGH M.-CROKAERT F.-ENGELHARD D.-MARCHETTI O.- AKAN H.-SKOUTELIS A.-KORTEN V.-VANDERCAM M.-GAYA H.-PADMOS A.-KLASTERSKY J.-ZINNER S.-GLAUSER M.- CALANDRA T.-VISCOLI C.
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin/tazobactam monotherapy.
Clin. Infect. Dis. 37:382/389, 2003
PubMed Abstract
CONIO M.-BLANCHI S.-LAPERTOSA G.-FERRARIS R.-SABLICH R.-MARCHI S.-D'ONOFRIO V.-LACCHIN T.- IAQUINTO G.-MISSALE G.-RAVELLI P.-CESTARI R.-BENEDETTI G.-MACRI' G.-FIOCCA R.-MUNIZZI F.- FILIBERTI R.
Long term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
Am. J. Gastroenterol. 98:1931/1939, 2003
PubMed Abstract
CONIO M.-LAPERTOSA G.-BLANCHI S.-FILIBERTI R.
Barrett's esophagus: an update.
Crit. Rev. Oncol. Hematol. 46:187/206, 2003
PubMed Abstract
CONSOLANDI C.-BUSTI E.-PERA C.-DELFINO L.-FERRARA G.B.-BORDONI R.-CASTIGLIONI B.- ROSSI BERNARDI L.-BATTAGLIA C.-DE BELLIS G.
Detection of HLA polymorphisms by ligase detection reaction and a universal array format: a pilot study for low resolution genotyping.
Hum. Immunol. 64:168/178, 2003
PubMed Abstract
CONTINI P.-GHIO M.-POGGI A.-FILACI G.-INDIVERI F.-FERRONE S.-PUPPO F.
Soluble HLA/A,/B,/C and /G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Eur. J. Immunol. 33:125/134, 2003
PubMed Abstract
CORSARO A.-THELLUNG S.-VILLA V.-ROSSI D.-PALUDI D.-ARENA S.-MILLO E.-SCHETTINI D.-DAMONTE G.- ACETO A.-SCHETTINI G.-FLORIO T.
Prion protein fragment 106/126 induces a p38 MAP kinase dependent apoptosis in SH/SY5Y neuroblastoma cells independently from the amyloid fibril formation.
Ann. N.Y. Acad. Sci. 1010:610/622, 2003
PubMed Abstract
CORVO' R.-PASTRONE I.-SCOLARO T.-MARCENARO M.-BERRETTA L.-CHIARA S.
Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.
Tumori 89:361/367, 2003
COSTA P.-RUSCONI S.-FOGLI M.-MAVILIO D.-MURDACA G.-PUPPO F.-MINGARI M.C.-GALLI M.-MORETTA L.- DE MARIA A.
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long term non progressor HIV/1 infected patients. Letter.
AIDS 17:257/260, 2003
PubMed Abstract
COSTANTINI M.-HIGGINSON I.-BONI L.-ORENGO M.-GARRONE E.-HENRIQUET F.-BRUZZI P.
Effect of a palliative home care team on hospital admissions among patients with advanced cancer.
Palliat. Med. 17:315/321, 2003
PubMed Abstract
COSTANTINI M.-SCIALLERO S.-GIANNINI A.-GATTESCHI B.-RINALDI P.-LANZANOVA G.-BONELLI L.-CASETTI T.- BERTINELLI E.-GIULIANI O.-CASTIGLIONE G.-MANTELLINI P.-NALDONI C.-BRUZZI P.
Interobserver agreement in the histologic diagnosis of colorectal polyps: the experience of the multicenter adenoma colorectal study (SMAC).
J. Clin. Epidemiol. 56:209/214, 2003
PubMed Abstract
COTELLESSA M.-BARBIERI P.- MAZZELLA M.-BONASSI S.-MINICUCCI L.-LORINI R.
High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998.
Diabetes Care 26:1786/1789, 2003
PubMed Abstract
CROCE M.-DE AMBROSIS A.-CORRIAS M.-PISTOIA V.-OCCHINO M.-MEAZZA R.-GIRON J.-AZZARONE B.-ACCOLLA R. -FERRINI S.
Different levels of control prevent interferon gamma inducible HLA class II expression in human neuroblastoma cells.
Oncogene 22:7848/7857, 2003
PubMed Abstract
CUTRONA G.-CARPANETO E.-PONZANELLI A.-ULIVI M.-MILLO E.-SCARFI' S.-RONCELLA S.-BENATTI U.- BOFFA L.-FERRARINI M.
Inhibition of the translocated c/myc in Burkitt's lymphoma by a PNA complementary to the E micro enhancer.
Cancer Res. 63:6144/6148, 2003
PubMed Abstract
DAL MASO L.-FRANCESCHI S.-POLESEL J.-BRAGA C.-PISELLI P.-CROCETTI E.-FALCINI F.-GUZZINATI S.- ZANETTI R.-VERCELLI M.-REZZA G.
Risk of cancer in persons with AIDS in Italy, 1985/1998.
Br. J. Cancer 89:94/100, 2003
PubMed Abstract
D'ALESSIO A.-CALIFANO D.-INCORONATO M.-SANTELLI G.-FLORIO T.-SCHETTINI G.-CARLOMAGNO M.-CERCHIA L.- DE FRANCISCIS V.
The tyrosine phosphatase Shp/2 mediates intracellular signaling initiated by ret mutants.
Endocrinology 144:4298/4305, 2003
PubMed Abstract
D'ARRIGO C.-BARBORO P.-MORMINO M.-CORADEGHINI R.-PARODI S.-PATRONE E.-BALBI C.
DNA supercoiling in apoptotic chromatin.
Biochem. Biophys. Res. Commun. 309:540/546, 2003
PubMed Abstract
DE BERNARDI B.-NICOLAS B.-BONI L.-INDOLFI P.-CARLI M.-CORDERO L.-DONFRANCESCO A.-PESSION A.- PROVENZI M.-DI CATALDO A.-RIZZO A.-TONINI G.P.-DALLORSO S.-CONTE M.-GAMBINI C.-GARAVENTA A.- BONETTI F.-ZANAZZO A.-D'ANGELO P.-BRUZZI P.
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high dose protocols adopted by the Italian Cooperative Group for Neuroblastoma.
J. Clin. Oncol. 21:1592/1601, 2003
PubMed Abstract
DE BRAUD F.-KHAYAT D.-KROON B.-VALDAGNI R.-BRUZZI P.-CASCINELLI N.
Malignant melanoma.
Crit. Rev. Oncol. Hematol. 47:35/63, 2003
PubMed Abstract
DE CUPIS A.-SEMINO C.-PIRANI P.-LOPREVITE M.-ARDIZZONI A.-FAVONI R.
Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines.
Eur. J. Pharmacol. 473:83/95, 2003
PubMed Abstract
DELFINO L.-MORABITO A.-FERRARA G.B.
HLA/C sequence based typing: nucleotide analysis from exon 1 through exon 8. Identification of a new allele: Cw*0718.
Tissue Antigens 62:418/425, 2003
PubMed Abstract
DELLA CHIESA M.-VITALE M.-CARLOMAGNO S.-FERLAZZO G.-MORETTA L.-MORETTA A.
The natural killer cell mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig like receptors.
Eur. J. Immunol. 33:1657/1666, 2003
PubMed Abstract
DEL MASTRO L.
Utilizzo di epoetina nei pazienti neoplastici. Linee guida dell'ASCO e dell'ASH per la pratica clinica basate sull'evidenza.
Tumori 89:1/12, 2003
PubMed Abstract
DE PAS T.-CASALI P.-TOMA S.-ROMANINI A.-MASSIDDA B.-COMANDONE A.-LABIANCA R.- MASSACESI C.-TUCCI A.-ANTIMI M.-BIASCO G.-AGLIETTA M.-APICE G.-DE BRAUD F.
Gastrointestinal stromal tumors: should they be treated with the same systemic chemotherapy as other soft tissue sarcomas? A cooperative study by the Italian Sarcoma Group. Letter.
Oncology 64:186/188, 2003
PubMed Abstract
DERUBEIS A.-MASTROGIACOMO M.-CANCEDDA R.-QUARTO R.
Osteogenic potential of rat spleen stromal cells.
Eur. J. Cell Biol. 82:175/181, 2003
PubMed Abstract
DE SPIRITO M.-ARCOVITO G.-PAPI M.-ROCCO M.-FERRI F.
Small and wide angle elastic light scattering study of fibrin structure.
J. Appl. Crystallogr. 36:636/641, 2003
DE TOTERO D.-TAZZARI P.-CAPAIA M.-MONTERA M.-CLAVIO M.-BALLEARI E.-FOA R.-GOBBI M.
CD40 triggering enhances fludarabine induced apoptosis of chronic lymphocytic leukemia B cells through autocrine release of tumor necrosis factor alpha and interferon gamma and tumor necrosis factor receptor I/II upregulation.
Haematologica 88:148/158, 2003
PubMed Abstract
DI COSTANZO F.-SOBRERO A.-GASPERONI S.-DOGLIOTTI L.-FRASSINETI L.-FALCONE A.-LIONETTO R.-BRUZZI P.- LUPPI G.-GALLO L.-CONTE P.-COMANDONE A.-TURCI D.-MARZOLA M.-FOLCO U.-PFANNER E.-MESTRINER M.- BONI C.-GALLI C.-TONATO M.-ROSSO R.
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
Ann. Oncol. 14:1365/1372, 2003
PubMed Abstract
DI MARCO E.-SESSAREGO N.-ZEREGA B.-CANCEDDA R.-DESCALZI F.
Inhibition of cell proliferation and induction of apoptosis by exFABP gene targeting.
J. Cell. Physiol. 196:464/473, 2003
PubMed Abstract
DONA' M.-DELL'AICA I.-CALABRESE F.-BENELLI R.-MORINI M.-ALBINI A.-GARBISA S.
Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis.
J. Immunol. 170:4335/4341, 2003
PubMed Abstract
DONO M.-ZUPO S.-COLOMBO M.-MASSARA R.-GAIDANO G.-TABORELLI G.-CEPPA P.-BURGIO V.- CHIORAZZI N.-FERRARINI M.
The human marginal zone B cell.
Ann. N.Y. Acad. Sci. 987:117/124, 2003
PubMed Abstract
DZIADZIUSZKO R.-ARDIZZONI A.-POSTMUS P.-SMIT E.-PRICE A.-DEBRUYNE C.-LEGRAND C.-GIACCONE G.
Temozolomide in patients with advanced non small cell lung cancer with and without brain metastases: a phase II study of the EORTC Lung Cancer Group (08965).
Eur. J. Cancer 39:1271/1276, 2003
PubMed Abstract
EMIONITE L.-GALMOZZI F.-RAFFO P.-VERGANI L.-TOMA S.
Retinois and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line.
Anticancer Res. 23:13/20, 2003
PubMed Abstract
FEARON K.-VON MEYENFELDT M.-MOSES A.-VAN GEENEN R.-ROY A.-GOUMA D.-GIACOSA A.-VAN GOSSUM A.- BAUER J.-BARBER M.-AARONSON N.-VOSS A.-TISDALE M.
Effect of a protein and energy dense n/3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
Gut 52:1479/1486, 2003
PubMed Abstract
FENECH M.-BONASSI S.-TURNER J.-LANDO C.-CEPPI M.-CHANG W.-HOLLAND N.-KIRSCH M.-ZEIGER E.-BIGATTI M. -BOLOGNESI C.-CAO J.-DE LUCA G.-DI GIORGIO M.-FERGUSON L.-FUCIC A.-LIMA O.-HADJIDEKOVA V.-HRELIA P. -JAWORSKA A.-JOKSIC G.-KRISHNAJA A.-LEE T.-MARTELLI A.-McKAY M.-MIGLIORE L.-MIRKOVA E.-MULLER W.- ODAGIRI Y.-ORSIERE T.-SCARFI M.-SILVA M.-SOFUNI T.-SURALLES J.-TRENTA G.-VOROBTSOVA I.-VRAL A.- ZIJNO A.
Intra and inter laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide scoring exercise by the HUMN project.
Mutat. Res. Gen. Tox. En. 534:45/64, 2003
PubMed Abstract
FENECH M.-CHANG W.-KIRSCH M.-HOLLAND N.-BONASSI S.-ZEIGER E.
HUMN project: detailed description of the scoring criteria for the cytokinesis block micronucleus assay using isolated human lymphocyte cultures.
Mutat. Res. Gen. Tox. En. 534:65/75, 2003
PubMed Abstract
FERLAZZO G.-MORANDI B.-D'AGOSTINO A.-MEAZZA R.-MELIOLI G.-MORETTA A.-MORETTA L.
The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells.
Eur. J. Immunol. 33:306/313, 2003
PubMed Abstract
FERRARI N.-MORINI M.-PFEFFER U.-MINGHELLI S.-NOONAN D.-ALBINI A.
Inhibition of Kaposi's sarcoma in vivo by fenretinide.
Clin. Cancer Res. 9:6020/6029, 2003
PubMed Abstract
FERRARI N.-PALEARI L.-PALMISANO G.-TAMMARO P.-LEVI G.-ALBINI A.-BRIGATI C.
Induction of apoptosis by fenretinide in tumor cell lines correlates with DLX2, DLX3 and DLX4 gene expression.
Oncol. Rep. 10:973/977, 2003
PubMed Abstract
FERRARI N.-PALMISANO G.-PALEARI L.-BASSO G.-MANGIONI M.-FIDANZA V.-ALBINI A.-CROCE C.-LEVI G.- BRIGATI C.
DLX genes as targets of ALL/1: DLX 2,3,4 down regulation in t(4;11) acute lymphoblastic leukemias.
J. Leukoc. Biol. 74:302/305, 2003
PubMed Abstract
FERRARINI M.-MANGIOLA M.-CUTRONA G.-ZUPO S.
Recent views on B cell chronic lymphocytic leukemia pathophysiology.
Haematologica 88(suppl): 26/27, 2003
FERRERA L.-CAPONNETTO C.-MARINI V.-RIZZI D.-BORDO D.-PENCO S.-AMOROSO A.-ORIGONE P.-GARRE' C.
An italian dominant FALS Leu144Phe SOD1 mutation: genotype phenotype correlation.
Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4:167/170, 2003
PubMed Abstract
FERRERO E.-BELLONI D.-CONTINI P.-FOGLIENI C.-FERRERO M.-FABBRI M.-POGGI A.-ZOCCHI M.
Transendothelial migration leads to protection from starvation induced apoptosis in CD34+CD14+ circulating precursors: evidence for PECAM/1 involvement through Akt/PKB activation.
Blood 101:186/193, 2003
PubMed Abstract
FERRO P.-FORLANI A.-MUSELLI M.-PFEFFER U.
Alternative splicing of the human estrogen receptor alpha primary transcript: mechanisms of exon skipping.
Int. J. Mol. Med. 12:355/363, 2003
PubMed Abstract
FIORINO C.-SANGUINETI G.-COZZARINI C.-FELLIN G.-FOPPIANO F.-MENEGOTTI L.-PIAZZOLLA A.-VAVASSORI V.- VALDAGNI R.
Rectal dose volume constraints in high dose radiotherapy of localized prostate cancer.
Int. J. Radiat. Oncol. Biol. Phys. 57:953/962, 2003
PubMed Abstract
FLORIO T.-ARENA S.-PATTAROZZI A.-THELLUNG S.-CORSARO A.-VILLA V.-MASSA A.-DIANA F.-SPOTO G.- FORCELLA S.-DAMONTE G.-FILOCAMO M.-BENATTI U.-SCHETTINI G.
Basic fibroblast growth factor activates endothelial nitric oxide synthase in CHO/K1 cells via the activation of ceramide synthesis.
Mol. Pharmacol. 63:297/310, 2003
PubMed Abstract
FLORIO T.-MONTELLA L.-CORSARO A.-DE CHIARA A.-APICE G.-FAZIOLI F.-LASTORIA S.-SCHETTINI G.- PALMIERI G.
In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors.
Anticancer Res. 23:2465/2471, 2003
PubMed Abstract
FLORIO T.-MORINI M.-VILLA V.-ARENA S.-CORSARO A.-THELLUNG S.-CULLER M.-PFEFFER U.-NOONAN D.- SCHETTINI G.-ALBINI A.
Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor 3 mediated regulation of endothelial nitric oxide synthase and mitogen activated protein kinase activities.
Endocrinology 144:1574/1584, 2003
PubMed Abstract
FLORIO T.-PALUDI D.-VILLA V.-ROSSI D.-CORSARO A.-MILLO E.-DAMONTE G.-D'ARRIGO C.-RUSSO C.- SCHETTINI G.-ACETO A.
Contribution of two conserved glycine residues to fibrillogenesis of the 106/126 prion protein fragment. Evidence that a soluble variant of the 106/126 peptide is neurotoxic.
J. Neurochem. 85:62/72, 2003
PubMed Abstract
FLORIO T.-THELLUNG S.-CORSARO A.-BOCCA L.-ARENA S.-PATTAROZZI A.-VILLA V.-MASSA A.-DIANA F.- SCHETTINI D.-BARBIERI F.-RAVETTI J.-SPAZIANTE R.-GIUSTI M.-SCHETTINI G.
Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH secreting pituitary adenoma cells in vitro.
Clin. Endocrinol. (Oxf) 59:115/128, 2003
PubMed Abstract
FOPPIANO F.-FIORINO C.-FREZZA G.-GRECO C.-VALDAGNI R.
The impact of contouring uncertainty on rectal 3D dose volume data: results of a dummy run in a multicenter trial (AIROPROS01/02).
Int. J. Radiat. Oncol. Biol. Phys. 57:573/579, 2003
PubMed Abstract
FRANCESCHI S.-DAL MASO L.-PEZZOTTI P.-POLESEL J.-BRAGA C.-PISELLI P.-SERRAINO D.-TAGLIABUE G.- FEDERICO M.-FERRETTI S.-DE LISI V.-LA ROSA F.-CONTI E.-BUDRONI M.-VICARIO G.-PIFFER S.-PANNELLI F. -GIACOMIN A.-BELLU' F.-TUMINO R.-FUSCO M.-REZZA G.-Cancer AIDS Registry Linkage Study- VERCELLI M.-ORENGO M.
Incidence of AIDS defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986/1998.
J. Acquir. Immune Defic. Syndr. 34:84/90, 2003
PubMed Abstract
GAMBINI C.-CONTE M.-BERNINI G.-ANGELINI P.-PESSION A.-PAOLUCCI P.-DONFRANCESCO A.-VENESELLI E.- MAZZOCCO K.-TONINI G.P.-RAFFAGHELLO L.-DOMINICI C.-MORANDO A.-NEGRI F.-FAVRE A.-DE BERNARDI B.- PISTOIA V.
Neuroblastic tumors associated with opsoclonus myoclonus syndrome: histological, immunohistochemical and molecular features of 15 italian cases.
Virchows Arch. 442:555/562, 2003
PubMed Abstract
GAMBINI C.-SEMENTA A.-BONI L.-MARINO C.-CROCE M.-NEGRI F.-PISTOIA V.-FERRINI S.-CORRIAS M.
Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progression.
Cancer Immunol. Immunother. 52:116/120, 2003
PubMed Abstract
GARAVENTA A.-LUKSCH R.-LO PICCOLO M.-CAVADINI E.-MONTALDO P.-PIZZITOLA M.-BONI L.-PONZONI M.- DECENSI A.-DE BERNARDI B.-FOSSATI F.-FORMELLI F.
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.
Clin. Cancer Res. 9:2032/2039, 2003
PubMed Abstract
GATTA G.-CORAZZIARI I.-MAGNANI C.-PERIS R.-ROAZZI P.-STILLER C.-EUROCARE Working Group-VERCELLI M.
Childhood cancer survival in Europe.
Ann. Oncol. 14(suppl):V119/V127, 2003
PubMed Abstract
GIACOSA A.-JANSSENS J.-STOCKBRUGGER R.
New avenues in cancer prevention.
Eur. J. Cancer Prev. 12:247/249, 2003
PubMed Abstract
GIANNONI P.-HUNZIKER E.
Release kinetics of transforming growth factor beta1 from fibrin clots.
Biotechnol. Bioeng. 83:121/123, 2003
PubMed Abstract
GIARETTI W.-VENESIO T.-SCIUTTO A.-PREVOSTO C.-GEIDO E.-RISIO M.
Near diploid and near triploid human sporadic colorectal adenocarcinomas differ for KRAS2 and TP53 mutational status.
Genes Chromosomes Cancer 37:207/213, 2003
PubMed Abstract
GIEBEL S.-LOCATELLI F.-LAMPARELLI T.-VELARDI A.-DAVIES S.-FRUMENTO G.-MACCARIO R.-BONETTI F.- WOJNAR J.-MARTINETTI M.-FRASSONI F.-GIORGIANI G.-BACIGALUPO An.-HOLOWIECKI J.
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.
Blood 102:814/819, 2003
PubMed Abstract
GIORDA E.-SIBILIO L.-MARTAYAN A.-MORETTI S.-VENTURO I.-MOTTOLESE M.-FERRARA G.B.-CAPPELLACCI S.- EIBENSCHUTZ L.-CATRICALA' C.-GRAMMATICO P.-GIACOMINI P.
The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Cancer Res. 63:4119/4127, 2003
PubMed Abstract
GIORDANI L.-BRUZZI P.-LASALANDRA C.-QUARANTA M.-SCHITTULLI F.-DELLA RAGIONE F.-IOLASCON A.
Association of breast cancer and polymorphisms of interleukin/10 and tumor necrosis factor alpha genes.
Clin. Chem. 49:1664/1667, 2003
PubMed Abstract
GIRON MICHEL J.-CAIGNARD A.-FOGLI M.-BROUTY D.-BRIARD D.-VAN DIJK M.-MEAZZA R.-FERRINI S.- LEBOUSSE C.-CLAY D.-BOMPAIS H.-CHOUAIB S.-PEAULT B.-AZZARONE B.
Differential STAT3, STAT5, and NF/kappaB activation in human hematopoietic progenitors by endogenous interleukin/15: implications in the expression of functional molecules.
Blood 102:109/117, 2003
PubMed Abstract
GIRON MICHEL J.-FOGLI M.-GAGGERO A.-FERRINI S.-CAIGNARD A.-BROUTY D.-BAOUZ S.-LE BOUSSE M.- PEAULT B.-VAN DIJK M.-BULFONE S.-DURALI D.-CHOUAIB S.-AZZARONE B.
Detection of a functional hybrid receptor gamma c/GM/CSFR beta in human hematopoietic CD34+ cells.
J. Exp. Med. 197:763/775, 2003
PubMed Abstract
GIUNTI D.-BORSELLINO G.-BENELLI R.-MARCHESE M.-CAPELLO E.-VALLE M.-PEDEMONTE E.-NOONAN D.- ALBINI A.-BERNARDI G.-MANCARDI G.-BATTISTINI L.-UCCELLI A.
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.
J. Leukoc. Biol. 73:584/590, 2003
PubMed Abstract
GROSSI F.-BELVEDERE O.-ROSSO R.
Geography of clinical cancer research publications from 1995 to 1999.
Eur. J. Cancer 39:106/111, 2003
PubMed Abstract
GROSSI F.-LOPREVITE M.-CHIARAMONDIA M.-CEPPA P.-PERA C.-RATTO G.-SERRANO J.-FERRARA G.B.-COSTA R.- BONI L.-ARDIZZONI A.
Prognostic significance of K/ras, p53, bcl/2, PCNA, CD34 in radically resected non small cell lung cancers.
Eur J. Cancer 39:1242/1250, 2003
PubMed Abstract
GUENZI E.-TOPOLT K.-LUBESEDER C.-JORG A.-NASCHBERGER E.-BENELLI R.-ALBINI A.-STURZL M.
The guanylate binding protein/1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP/1 expression.
EMBO J. 22:3772/3782, 2003
PubMed Abstract
HADJIDEKOVA V.-BULANOVA M.-BONASSI S.-NERI M.
Micronucleus frequency is increased in peripheral blood lymphocytes of nuclear power plant workers.
Radiat. Res. 160:684/690, 2003
PubMed Abstract
HALIN C.-GAFNER V.-VILLANI M.-BORSI L.-BERNDT A.-KOSMEHL H.-ZARDI L.-NERI D.
Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
Cancer Res. 63:3202/3210, 2003
PubMed Abstract
HANTGAN R.-LYLES D.-MALLETT T.-ROCCO M.-NAGASWAMI C.-WEISEL J.
Ligand binding promotes the entropy driven oligomerization of integrin alpha IIb beta3.
J. Biol. Chem. 278:3417/3426, 2003
PubMed Abstract
HAUPTMANN S.-BUDIANTO D.-DENKERT C.-KOBEL M.-BORSI L.-SIRI A.
Adhesion and migration of HRT/18 colorectal carcinoma cells on extracellular matrix components typical for the desmoplastic stroma of colorectal adenocarcinomas.
Oncology 65:174/181, 2003
PubMed Abstract
HAUPTMANN S.-SIEGERT A.-BERGER S.-DENKERT C.-KOBEL M.-OTT S.-SIRI A.-BORSI L.
Regulation of cell growth and the expression of extracellular matrix proteins in colorectal adenocarcinoma: a fibroblast tumor cell coculture model to study tumor host interactions in vitro.
Eur. J. Cell Biol. 82:1/8, 2003
PubMed Abstract
HIROI N.-KINO T.-BASSETT M.-RAINEY W.-PHUNG M.-ABU ASAB M.-FOJO T.-BRIATA P.-CHROUSOS G.- BORNSTEIN S.
Pituitary homeobox factor 1, a novel transcription factor in the adrenal regulating steroid 11ss hydroxylase.
Horm. Metab. Res. 35:273/278, 2003
PubMed Abstract
Italian Group Evaluation Outcomes Oncology (IGEO)-COSTANTINI M.-VITALE V.
Non clinical factors as determinants of the use of breast conservative surgery in Italy.
Tumori 89:168/172, 2003
PubMed Abstract
IWAMOTO M.-KITAGAKI J.-TAMAMURA Y.-GENTILI C.-KOYAMA E.-ENOMOTO H.-KOMORI T.-PACIFICI M.-ENOMOTO M.
Runx2 expression and action in chondrocytes are regulated by retinoid signaling and parathyroid hormone related peptide (PTHrP).
Osteoarthritis Cartilage 11:6/15, 2003
PubMed Abstract
JANSSENS J.-GIACOSA A.-STOCKBRUGGER R.
The European Community expansion and cancer burden.
Eur. J. Cancer Prev. 12:353/354, 2003
PubMed Abstract
KARADIMITRIS A.-ARATEN D.-LUZZATTO L.-NOTARO R.
Severe telomere shortening in patients with paroxysmal nocturnal hemoglobinuria affects both GPI- and GPI+ hematopoiesis.
Blood 102:514/516, 2003
PubMed Abstract
LEVI G.-PUCHE A.-MANTERO S.-BARBIERI O.-TROMBINO S.-PALEARI L.-EGEO A.-MERLO G.
The Dlx5 homeodomain gene is essential for olfactory development and connectivity in the mouse.
Mol. Cell. Neurosci. 22:530/543, 2003
PubMed Abstract
LICITRA L.-BERNIER J.-CVITKOVIC E.-GRANDI C.-SPINAZZE' S.-BRUZZI P.-GATTA G.-MOLINARI R.
Cancer of the nasopharynx.
Crit. Rev. Oncol. Hematol. 45:199/214, 2003
PubMed Abstract
LICITRA L.-GRANDI C.-PROTT F.-SCHORNAGEL J.-BRUZZI P.-MOLINARI R.
Major and minor salivary glands tumours.
Crit. Rev. Oncol. Hematol. 45:215/225, 2003
PubMed Abstract
LUNARDI G.-VANNOZZI M.-BIGHIN C.-DEL MASTRO L.-STEVANI I.-SCHETTINI G.-VENTURINI M.
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients.
Ann. Oncol. 14:1222/1226, 2003
PubMed Abstract
MACCALLI C.-PENDE D.-CASTELLI C.-MINGARI M.C.-ROBBINS P.-PARMIANI G.
NKG2D engagement of colorectal cancer specific T cells strengthens TCR mediated antigen stimulation and elicits TCR independent anti tumor activity.
Eur. J. Immunol. 33:2033/2043, 2003
PubMed Abstract
MANZITTI C.-MEREU P.-HAUPT R.-DI BLASI A.-FOSSATI F.-DALLORSO S.
Parotid carcinoma after autologous bone marrow transplantation for relapsed nephroblastoma.
J. Pediatr. Hematol. Oncol. 25:672/673, 2003
PubMed Abstract
MARCENARO E.-AUGUGLIARO R.-FALCO M.-CASTRICONI R.-PAROLINI S.-SIVORI S.-ROMEO E.-MILLO R.-MORETTA L.- BOTTINO C.-MORETTA A.
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell mediated cytotoxicity.
Eur. J. Immunol. 33:3367/3376, 2003
PubMed Abstract
MARIANI M.-CARPANETO E.-ULIVI M.-ALLFREY V.-BOFFA L.
Correlation between butyrate induced histone hyperacetylation turn over and c/myc expression.
J. Steroid Biochem. Mol. Biol. 86:167/171, 2003
PubMed Abstract
MARINACCIO A.-NESTI M.-Regional Operational Centers-GENNARO V.-MONTANARO F.-LAZZAROTTO A.- BIANCHELLI M.-CELESIA M.
Analysis of survival of mesothelioma cases in the italian register (ReNaM).
Eur. J. Cancer 39:1290/1295, 2003
PubMed Abstract
MASCI E.-CAVALLINI G.-MARIANI A.-FRULLONI L.-TESTONI P.-CURIONI S.-TITTOBELLO A.-UOMO G.- COSTAMAGNA G.-ZAMBELLI S.-MACARRI G.-INNOCENTI P.-DRAGONETTI C.-Gabexate Digestive Endoscopy Italian Group II-PUGLIESE V.
Comparison of two dosing regimens of gabexate in the prophylaxisof post ERCP pancreatitis.
Am. J. Gastroenterol. 98:2182/2186, 2003
PubMed Abstract
MATTEI D.-MORDINI N.-LO NIGRO C.-GALLAMINI A.-OSENDA M.-PUGNO F.-VISCOLI C.
Successful treatment of Acremonium fungemia with voriconazole.
Mycoses 46:511/514, 2003
PubMed Abstract
MEAZZA R.-COMES A.-ORENGO A.-FERRINI S.-ACCOLLA R.
Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells.
Eur. J. Immunol. 33:1183/1192, 2003
PubMed Abstract
MELIOLI G.-SEMINO C.-MARGARINO G.-MEREU P.-SCALA M.-CANGEMI G.-CROCETTI E.-MACHI' A.-FERLAZZO G.
Expansion of natural killer cells in patients with head and neck cancer: detection of noninhibitory (activating) killer Ig like receptors on circulating natural killer cells.
Head Neck 25:297/305, 2003
PubMed Abstract
MILIGI L.-SENIORI A.-BOLEJACK V.-VERALDI A.-BENVENUTI A.-NANNI O.-RAMAZZOTTI V.-TUMINO R.- STAGNARO E.-RODELLA S.-FONTANA A.-VINDIGNI C.-VINEIS P.
Non Hodgkin's lymphoma, leukemia, and exposures in agriculture: results from the italian multicenter case control study.
Am. J. Ind. Med. 44:627/636, 2003
PubMed Abstract
MONTANARO F.-BRAY F.-GENNARO V.-MERLER E.-TYCZYNSKI J.-MAXWELL D.
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends.
Cancer Causes Control 14:791/803, 2003
MONTI P.-CAMPOMENOSI P.-CIRIBILLI Y.-IANNONE R.-APRILE A.-INGA A.-TADA M.-MENICHINI P.- ABBONDANDOLO A.-FRONZA G.
Characterization of the p53 mutants ability to inhibit p73beta transactivation using a yeast based functional assay.
Oncogene 22:5252/5260, 2003
PubMed Abstract
MORABITO F.-MANGIOLA M.-RAPEZZI D.-ZUPO S.-OLIVA B.-FERRARIS A.-SPRIANO M.-ROSSI E.-STELITANO C.- CALLEA V.-CUTRONA G.-FERRARINI M.
Expression of CD10 by B chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Haematologica 88:864/873, 2003
PubMed Abstract
MORETTA L.-BOTTINO C.-FERLAZZO G.-PENDE D.-MELIOLI G.-MINGARI M.C.-MORETTA A.
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic.
Cell. Mol. Life Sci. 60:2139/2146, 2003
PubMed Abstract
MORETTA L.-FERLAZZO G.-MINGARI M.C.-MELIOLI G.-MORETTA A.
Update on natural killer cells: cross talk with dendritic cells and role in the cure of acute myeloid leukemias.
Cancer J. 9:232/237, 2003
PubMed Abstract
MORETTA L.-FERLAZZO G.-MINGARI M.C.-MELIOLI G.-MORETTA A.
Human natural killer cell function and their interactions with dendritic cells.
Vaccine 21(suppl):38/42, 2003
PubMed Abstract
MORETTA L.-MINGARI M.C.-BOTTINO C.-PENDE D.-BIASSONI R.-MORETTA A.
Cellular and molecular basis of natural killer and natural killer like activity.
Immunol. Lett. 88:89/93, 2003
PubMed Abstract
MORETTA L.-ROMAGNANI C.-PIETRA G.-MORETTA A.-MINGARI M.C.
NK/CTLs, a novel HLA/E restricted T cell subset.
Trends Immunol. 24:136/143, 2003
PubMed Abstract
MURAGLIA A.-CORSI A.-RIMINUCCI M.-MASTROGIACOMO M.-CANCEDDA R.-BIANCO P.-QUARTO R.
Formation of a chondro osseous rudiment in micromass cultures of human bone marrow stromal cells.
J. Cell Sci. 116:2949/2955, 2003
PubMed Abstract
MUSIO A.-MONTAGNA C.-ZAMBRONI D.-INDINO E.-BARBIERI O.-CITTI L.-VILLA A.-RIED T.-VEZZONI P.
Inhibition of BUB1 results in genomic instability and anchorage independent growth of normal human fibroblasts.
Cancer Res. 63:2855/2863, 2003
PubMed Abstract
NAKAJI S.-UMEDA T.-SHIMOYAMA T.-SUGAWARA K.-TAMURA K.-FUKUDA S.-SAKAMOTO J.-PARODI S.
Environmental factors affect colon carcinoma and rectal carcinoma in men and women differently.
Int. J. Colorectal Dis. 18:481/486, 2003
PubMed Abstract
NENCIONI A.-MULLER M.-GRUNEBACH F.-GARUTI A.-MINGARI M.C.-PATRONE F.-BALLESTRERO A.-BROSSART P.
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer.
Cancer Gene Ther. 10:209/214, 2003
PubMed Abstract
Neoadjuvant Chemotherapy for Cervical Cancer Meta Analysis Collaboration (NACCCMA)-CHIARA S.
Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta analysis of individual patient data from 21 randomised trial.
Eur. J. Cancer 39:2470/2486, 2003
PubMed Abstract
NERI M.-BETTA P.-MARRONI P.-FILIBERTI R.-CAFFERATA M.-MEREU C.-IVALDI G.-MONTANARO F.- PUNTONI R.-PAGANUZZI M.
Serum anti p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non neoplastic lung diseases.
Lung Cancer 39:165/172, 2003
PubMed Abstract
NERI M.-FUCIC A.-KNUDSEN L.-LANDO C.-MERLO F.-BONASSI S.
Micronuclei frequency in children exposed to environmental mutagens: a review.
Mutat. Res. Rev. Mutat. 544:243/254, 2003
PubMed Abstract
NERSESYAN A.-PERRONE E.-ROGGIERI P.-BOLOGNESI C.
Genotoxic action of cycloplatam, a new platinum antitumor drug, on mammalian cells in vivo and in vitro.
Chemotherapy 49:132/137, 2003
PubMed Abstract
NICOLO' M.-BIRO A.-CARDILLO F.-CASTELLANI P.-GIOVANNINI A.-MARIOTTI C.-ZINGIRIAN M.-NERI D.- ZARDI L.
Expression of extradomain B containing fibronectin in subretinal choroidal neovascular membranes.
Am. J. Ophthalmol. 135:7/13, 2003
PubMed Abstract
NOONAN D.-GRINGERI A.-MEAZZA R.-ROSSO O.-MAZZA S.-MUCA M.-LE BUANEC H.-ACCOLLA R.-ALBINI A.- FERRINI S.
Identification of immunodominant epitopes in inactivated Tat vaccinated healthy and HIV/1 infected volunteers.
J. Acquir. Immune Defic. Syndr. 33:47/55, 2003
PubMed Abstract
OGNIO E.-LAPIDE M.-OTTONE M.-MANDYS V.-PETERKA M.-PARODI Br.-VIALE M.
Embryo lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
Arch. Toxicol. 77:584/590, 2003
PubMed Abstract
ORENGO A.-DI CARLO E.-COMES A.-FABBI M.-PIAZZA T.-CILLI M.-MUSIANI P.-FERRINI S.
Tumor cells engineered with IL/12 and IL/15 genes induce protective antibody responses in nude mice.
J. Immunol. 171:569/575, 2003
PubMed Abstract
ORIGONE P.-DEFFERRARI R.-MAZZOCCO K.-LO CUNSOLO C.-DE BERNARDI B.-TONINI G.P.
Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma.
Am. J. Med. Genet. 118:309/313, 2003
PubMed Abstract
OTTAGGIO L.-VIAGGI S.-ZUNINO A.-ZUPO S.-ROSSI E.-SPRIANO M.-ABBONDANDOLO A.-FERRARINI M.
Chromosome aberrations evaluated by comparative genomic hybridization in B cell chronic lymphocytic leukemia: correlation with CD38 expression.
Haematologica 88:769/777, 2003
PubMed Abstract
OTTONELLO L.-CUTOLO M.-FRUMENTO G.-ARDUINO N.-BERTOLOTTO M.-MANCINI M.-SOTTOFATTORI E.-DALLEGRI F.
Fate of inflammatory neutrophils within the joint. Reply.
Rheumatology (Oxford) 42:1275/1276, 2003
PubMed Abstract
OWEN R.-HAUBNER R.-MIER W.-GIACOSA A.-HULL W.-SPIEGELHALDER B.-BARTSCH H.
Isolation, structure elucidation and antioxidant potential of the major phenolic and flavonoid compounds in brined olive drupes.
Food Chem. Toxicol. 41:703/717, 2003
PubMed Abstract
PAGANO A.-CROOIJMANS R.-GROENEN M.-RANDAZZO N.-ZEREGA B.-CANCEDDA R.-DOZIN B.
A chondrogenesis related lipocalin cluster includes a third new gene, CALgamma.
Gene 305:185/194, 2003
PubMed Abstract
PAGANO G.-YOUSSOUFIAN H.-European Research on Oxidative Stress (EUROS)-DEGAN P.
Fanconi anaemia proteins: major roles in cell protection against oxidative damage.
Bioessays 25:589/595, 2003
PubMed Abstract
PAGANUZZI M.-BOBBIO B.-MARRONI P.-FILIBERTI R.-SECCO G.-GROSSI C.
Prognostic role of serum Sialyl Lewis(x) (CD15s) in colorectal cancer.
Oncology 65:52/59, 2003
PubMed Abstract
PALMIERI D.-POGGI S.-ULIVI V.-CASARTELLI G.-MANDUCA P.
Pro collagen I COOH terminal trimer induces directional migration and metalloproteinases in breast cancer cells.
J. Biol. Chem. 278:3639/3647, 2003
PubMed Abstract
PARODI S.-MONTANARO F.-CEPPI M.-GENNARO V.
Mortality of petroleum refinery workers. Letter.
Occup. Environ. Med. 60:304/605, 2003
PubMed Abstract
PARODI S.-MUSELLI M.-FONTANA V.-BONASSI S.
ROC curves are a suitable and flexible tool for the analysis of gene expression profiles.
Cytogenet. Genome Res. 101:90/91, 2003
PubMed Abstract
PARODI S.-VERCELLI M.-STELLA A.-STAGNARO E.-VALERIO F.
Lymphohaematopoietic system cancer incidence in an urban area near a coke oven plant: an ecological investigation.
Occup. Environ. Med. 60:187/194, 2003
PubMed Abstract
PASTORINO F.-BRIGNOLE C.-MARIMPIETRI D.-CILLI M.-GAMBINI C.-RIBATTI D.-LONGHI R.-ALLEN T.-CORTI A. -PONZONI M.
Vascular damage and anti angiogenic effects of tumor vessel targeted liposomal chemotherapy.
Cancer Res. 63:7400/7409, 2003
PubMed Abstract
PERROTTA S.-LUZZATTO L.-CARELLA M.-IOLASCON A.
Congenital dyserythropoietic anemia type II in human patients is not due to mutations in the erythroid anion exchanger 1. Letter.
Blood 102:2704/2705, 2003
PubMed Abstract
PEZZATO E.-DONA' M.-SARTOR L.-DELL'AICA I.-BENELLI R.-ALBINI A.-GARBISA S.
Proteinase 3 directly activates MMP/2 and degrades gelatin and matrigel; differential inhibition by (-)epigallocatechin/3/gallate.
J. Leukoc. Biol. 74:88/94, 2003
PubMed Abstract
PFEFFER U.-FERRARI N.-MORINI M.-BENELLI R.-NOONAN D.-ALBINI A.
Antiangiogenic activity of chemopreventive drugs.
Int. J. Biol. Markers 18:70/74, 2003
PubMed Abstract
PFEFFER U.-NOONAN D.-ALBINI A.
Re: Microarray studies challenge theories of metastasis. Letter.
J. Natl. Cancer Inst. 95:829, 2003
PubMed Abstract
PICCARDO M.-STELLA A.-REDAELLI A.-MINOIA C.-VALERIO F.
Newsagents' daily personal exposures to benzo(a)pyrene in Genoa, Italy.
Atmos. Environ. 37:603/613, 2003
PIETRA G.-ROMAGNANI C.-MAZZARINO P.-FALCO M.-MILLO E.-MORETTA A.-MORETTA L.-MINGARI M.C.
HLA/E restricted recognition of cytomegalovirus derived peptides by human CD8+ cytolytic T lymphocytes.
Proc. Natl. Acad. Sci. USA 100:10896/10901, 2003
PubMed Abstract
PIETRA G.-ROMAGNANI C.-MAZZARINO P.-MILLO E.-MORETTA L.-MINGARI M.C.
Comparative analysis of NK or NK/CTL mediated lysis of immature or mature autologous dendritic cells.
Eur. J. Immunol. 33:3427/3432, 2003
PubMed Abstract
PISTILLO M.-TAZZARI P.-PALMISANO G.-PIERRI I.-BOLOGNESI A.-FERLITO F.-CAPANNI P.-POLITO L.-RATTA M. -PILERI S.-PICCIOLI M.-BASSO G.-RISSOTTO L.-CONTE R.-GOBBI M.-STIRPE F.-FERRARA G.B.
CTLA/4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells.
Blood 101:202/209, 2003
PubMed Abstract
PONASSI M.-CANTONI C.-BIASSONI R.-CONTE R.-SPALLAROSSA A.-MORETTA A.-MORETTA L.-BOLOGNESI M.- BORDO D.
Expression and crystallographic characterization of the extracellular domain of human natural killer cell triggering receptor NKp46.
Acta Crystallogr. D Biol. Crystallogr. 59:2259/2261, 2003
PubMed Abstract
PONASSI M.-CANTONI C.-BIASSONI R.-CONTE R.-SPALLAROSSA A.-PESCE A.-MORETTA A.-MORETTA L.- BOLOGNESI M.-BORDO D.
Structure of the human NK cell triggering receptor NKp46 ectodomain.
Biochem. Biophys. Res. Commun. 309:317/323, 2003
PubMed Abstract
PORCILE C.-STANZIONE S.-PICCIOLI P.-BAJETTO A.-BARBERO S.-BISAGLIA M.-BONAVIA R.-FLORIO T.- SCHETTINI G.
Pyrrolidinedithiocarbamate induces apoptosis in cerebellar granule cells: involvement of AP/1 and MAP kinases.
Neurochem. Int. 43:31/38, 2003
PubMed Abstract
PRATO N.-BANDERALI A.-NEUMAIER C.-DAHMANE M.-MARTINOLI C.-DERCHI L.
Calcific tendinitis of the rotator cuff as a cause of drooping shoulder.
Skeletal Radiol. 32:82/85, 2003
PubMed Abstract
PROFUMO A.-TURCI M.-DAMONTE G.-FERRI F.-MAGATTI D.-CARDINALI B.-CUNIBERTI C.-ROCCO M.
Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform specific effect at physiological Ca2+ concentration.
Biochemistry 42:12335/12348, 2003
PubMed Abstract
PUELLES E.-ACAMPORA D.-LACROIX E.-SIGNORE M.-ANNINO A.-TUORTO F.-FILOSA S.-CORTE G.-WURST W.- ANG S.-SIMEONE A.
Otx dose dependent integrated control of antero posterior and dorso ventral patterning of midbrain.
Nat. Neurosci. 6:453/460, 2003
PubMed Abstract
PUNTONI R.-FILIBERTI R.-CERRANO P.-NERI M.-ANDREATTA R.-BONASSI S.
Implementation of a molecular epidemiology approach to human pleural malignant mesothelioma.
Mutat. Res. Rev. Mutat. 544:385/396, 2003
PubMed Abstract
PUNTONI R.-PUNTONI M.-CEPPI M.
Re: Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. Letter.
J. Natl. Cancer Inst. 95:1552/1553, 2003
PubMed Abstract
PUNTONI R.-NERI M.-CERRANO P.-FILIBERTI R.
Re: Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. Letter.
J. Natl. Cancer Inst. 95:687/689, 2003
PubMed Abstract
PUTTHOFF P.-AKYUZ N.-KUTSCHE M.-ZARDI L.-BORGMEYER U.-SCHACHNER M.
Structure of the murine tenascin R gene and functional characterisation of the promoter.
Biochem. Biophys. Res. Commun. 308:940/949, 2003
PubMed Abstract
QUAGLIA A.-PARODI S.-GROSCLAUDE P.-MARTINEZ C.-COEBERGH J.-VERCELLI M.
Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe: an analysis of differential trends in incidence and mortality in France, Italy and Spain.
Eur. J. Cancer 39:654/665, 2003
PubMed Abstract
QUAGLIA A.-VERCELLI M.-PUPPO A.-CASELLA C.-ARTIOLI E.-CROCETTI E.-FALCINI F.-RAMAZZOTTI V.- TAGLIABUE G.
Prostate cancer in Italy before and during the PSA era: survival trend and prognostic determinants.
Eur. J. Cancer Prev. 12:145/152, 2003
PubMed Abstract
RAPEZZI D.-STICCHI L.-RACCHI O.-MANGERINI R.-FERRARIS A.-GAETANI G.
Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma.
Eur. J. Haematol. 70:225/230, 2003
PubMed Abstract
REPETTO L.-VANNOZZI M.-HAZINI A.-SESTINI A.-PIETROPAOLO M.-ROSSO R.
Anastrozole and quinapril can be safely coadministered to elderly women with breast cancer and hypertension: a pharmacokinetic study. Letter.
Ann. Oncol. 14:1587/1588, 2003
PubMed Abstract
ROAZZI P.-CAPOCACCIA R.-SANTAQUILANI M.-CARRANI E.-EUROCARE Working Group-VERCELLI M.
Electronic availability of EUROCARE/3 data: a tool for further analysis.
Ann. Oncol. 14(suppl):V150/V155, 2003
PubMed Abstract
ROMANI M.-TONINI G.P.-BANELLI B.-ALLEMANNI G.-MAZZOCCO K.-SCARUFFI P.-BONI L.-PONZONI M.-PAGNAN G.- RAFFAGHELLO L.-FERRINI S.-CROCE M.-CASCIANO I.
Biological and clinical role of p73 in neuroblastoma.
Cancer Lett. 197:111/117, 2003
PubMed Abstract
ROMANINI A.-TANGANELLI L.-CARNINO F.-FANUCCHI A.-LIONETTO R.-PASTORINO S.-COSIO S. -GADDUCCI A.-CONTE P.
First line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients.
Gynecol. Oncol. 89:354/359, 2003
PubMed Abstract
ROSANO' L.-SPINELLA F.-DI CASTRO V.-NICOTRA M.-ALBINI A.-NATALI P.-BAGNATO A.
Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.
Am. J. Pathol. 163:753/762, 2003
PubMed Abstract
ROSSI O.-BARBIERI O.-FROSINA G.
Time course of spontaneous transformation of CD/1 mouse embryonic fibroblasts.
Anticancer Res. 23:1373/1378, 2003
PubMed Abstract
RUSSO P.-ARZANI D.-TROMBINO S.-FALUGI C.
c/myc down regulation induces apoptosis in human cancer cell lines exposed to RPR/115135 (C31/H29/NO4), a non peptidomimetic farnesyltransferase inhibitor.
J. Pharmacol. Exp. Ther. 304:37/47, 2003
PubMed Abstract
SANGUINETI G.-FRANZONE P.-MARCENARO M.-FOPPIANO F.-VITALE V.
Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study.
Strahlenther. Onkol. 179:464/470, 2003
PubMed Abstract
SANGUINETI G.-MARCENARO M.-FRANZONE P.-FOPPIANO F.-VITALE V.
Neoadjuvant androgen deprivation and prostate gland shrinkage during conformal radiotherapy.
Radiother. Oncol. 66:151/157, 2003
PubMed Abstract
SANT M.-AARELEID T.-BERRINO F.-BIELSKA M.-CARLI P.-FAIVRE J.-GROSCLAUDE P.-HEDELIN G.-MATSUDA T.- MOLLER H.-MOLLER T.-VERDECCHIA A.-CAPOCACCIA R.-GATTA G.-MICHELI A.-SANTAQUILANI M.-ROAZZI P.- LISI D.-EUROCARE Working Group-VERCELLI M.
EUROCARE/3: survival of cancer patients diagnosed 1990/94, results and commentary.
Ann. Oncol. 14(suppl):V61/V118, 2003
PubMed Abstract
SANTIMARIA M.-MOSCATELLI G.-VIALE G.-GIOVANNONI L.-NERI G.-VITI F.-LEPRINI A.-BORSI L.- CASTELLANI P.-ZARDI L.-NERI D.-RIVA P.
Immunoscintigraphic detection of the ED/B domain of fibronectin, a marker of angiogenesis, in patients with cancer.
Clin. Cancer Res. 9:571/579, 2003
PubMed Abstract
SEGNAN N.-SENORE C.-BONELLI L.
Re: Baseline findings of the Italian Multicenter Randomized Controlled Trial of once only sigmoidoscopy/SCORE. Reply.
J. Natl. Cancer Inst. 95:1090, 2003
SIVORI S.-CANTONI C.-PAROLINI S.-MARCENARO E.-CONTE R.-MORETTA L.-MORETTA A.
IL/21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig like receptors.
Eur. J. Immunol. 33:3439/3447, 2003
PubMed Abstract
SODEINDE O.-CLARKE J.-VULLIAMY T.-LUZZATTO L.-MASON P.
Expression of Plasmodium falciparum G6PD/6PGL in laboratory parasites and in patient isolates in G6PD deficient and normal nigerian children.
Br. J. Haematol. 122:662/668, 2003
PubMed Abstract
SORMANI M.-BRUZZI P.-BECKMANN K.-WAGNER K.-MILLER D.-KAPPOS L.-FILIPPI M.
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta/1b.
Neurology 60:1462/1466, 2003
PubMed Abstract
SORMANI M.-ONETO R.-BRUNO B.-FIORONE M.-LAMPARELLI T.-GUALANDI F.-RAIOLA A.-DOMINIETTO A.- VAN LINT M.-FRASSONI F.-BRUZZI P.-BACIGALUPO A.
A revised day +7 predictive score for transplant related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose.
Bone Marrow Transplant. 32:205/211, 2003
PubMed Abstract
SPAGGIARI G.-CONTINI P.-NEGRINI S.-DONDERO A.-CAROSIO R.-GHIO M.-PUPPO F.-INDIVERI F.-ZOCCHI M.- POGGI A.
IFN/gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules.
Eur. J. Immunol. 33:3049/3059, 2003
PubMed Abstract
SPALLAROSSA A.-CARPEN A.-FORLANI F.-PAGANI S.-BOLOGNESI M.-BORDO D.
SseA, a 3/mercaptopyruvate sulfurtransferase from Escherichia coli: crystallization and preliminary crystallographic data.
Acta Crystallogr. D Biol. Crystallogr. 59:168/170, 2003
PubMed Abstract
SPALLAROSSA A.-FORLANI F.-PAGANI S.-SALVATI L.-VISCA P.-ASCENZI P.-BOLOGNESI M.-BORDO D.
Inhibition of Azotobacter vinelandii rhodanese by NO donors.
Biochem. Biophys. Res. Commun. 306:1002/1007, 2003
PubMed Abstract
TAIOLI E.-BONASSI S.
Pooled analysis of epidemiological studies involving biological markers.
Int. J. Hyg. Environ. Health 206:109/115, 2003
PubMed Abstract
TAN S.-DEAR K.-BRUZZI P.-MACHIN D.
Strategy for randomised clinical trials in rare cancers.
Br. Med. J. 327:47/49, 2003
PubMed Abstract
TANARA G.-FALUGI C.-CESARIO A.-MARGARITORA S.-RUSSO P.-COSIMI A.
TP53 codon 72 polymorphism does not affect risk of cervical cancer in patients from The Gambia.
Int. J. Biol. Markers 18:280/283, 2003
PubMed Abstract
TENCA C.-MERLO A.-ZARCONE D.-SAVERINO D.-BRUNO S.-DE SANTANNA A.-RAMARLI D.-FABBI M.-PESCE C.- DEAGLIO S.-CICCONE E.-MALAVASI F.-GROSSI C.
Death of T cell precursors in the human thymus: a role for CD38.
Int. Immunol. 15:1105/1116, 2003
PubMed Abstract
TINNERBERG H.-HEIKKILA P.-HUICI A.-BERNAL F.-FORNI A.-WANDERS S.-WELINDER H.- WILHARDT P.-STROMBERG U.-NORPPA H.-KNUDSEN L.-BONASSI S.-HAGMAR L.
Retrospective exposure assessment and quality control in an international multi centre case control study.
Ann. Occup. Hyg. 47:37/47, 2003
PubMed Abstract
TJAN HEIJNEN V.-CALEO S.-POSTMUS P.-ARDIZZONI A.-BURGHOUTS J.-BUCCHOLZ E.-BIESMA B. -GORLIA T.-CROTT R.-GIACCONE G.-DEBRUYNE C.-MANEGOLD C.
Economic evaluation of antibiotic prophylaxis in small cell lung cancer patients receiving chemotherapy: an EORTC double blind placebo controlled phase III study (08923).
Ann. Oncol. 14:248/257, 2003
PubMed Abstract
TOMA S.-BONELLI L.-SARTORIS A.-MIRA E.-ANTONELLI A.-BEATRICE F.-GIORDANO C.-BENAZZO M.-CAROGGIO A.- CAVALOT A.-GANDOLFO S.-GAROZZO A.-MARGARINO G.-SCHENONE G.-SPADINI N.-ZIBORDI F.-BALZARINI F.- SERAFINI I.-MIANI P.-CORTESINA G.
Beta carotene supplementation in patients radically treated for stage I/II head and neck cancer: results of a randomized trial.
Oncol. Rep. 10:1895/1901, 2003
PubMed Abstract
TOMA S.-CANAVESE G.-GRIMALDI A.-RAVERA G.-UGOLINI D.-PERCIVALE P.L.-BADELLINO F.
Concomitant chemo radiotherapy in the treatment of locally advanced and/or metastatic soft tissue sarcomas: experience of the National Cancer Institute of Genoa.
Oncol. Rep. 10:641/647, 2003
PubMed Abstract
TONINI G.P.-LONGO L.-COCO S.-PERRI P.
Familial neuroblastoma: a complex heritable disease.
Cancer Lett. 197:41/45, 2003
PubMed Abstract
TONINI G.P.-ROMANI M.
Genetic and epigenetic alterations in neuroblastoma.
Cancer Lett. 197:69/73, 2003
PubMed Abstract
TOSETTI F.-VENE' R.-ARENA G.-MORINI M.-MINGHELLI S.-NOONAN D.-ALBINI A.
N/(4/hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species mediated cell death.
Mol. Pharmacol. 63:565/573, 2003
PubMed Abstract
TRAGGIAI E.-PUZONE R.-LANZAVECCHIA A.
Antigen dependent and independent mechanisms that sustain serum antibody levels.
Vaccine 21(suppl):35/37, 2003
PubMed Abstract
UGOLINI D.-CASILLI C.
The visibility of italian journals.
Scientometrics 56:345/355, 2003
UGOLINI D.-MELA G.
Oncological research overview in the European Union. A 5 year survey.
Eur. J. Cancer 39:1888/1894, 2003
PubMed Abstract
VALENTE P.-ARZANI D.-CESARIO A.-MARGARITORA S.-CARBONE E.-RUSSO P.
TNF increases camptothecin induced apoptosis by inhibition of NF/kappaB.
Eur. J. Cancer 39:1468/1477, 2003
PubMed Abstract
VANNOZZI M.-OTTONE M.-MARIGGIO' M.-CAFAGGI S.-PARODI Br.-CILLI M.-LINDUP E.- VIALE M.
Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia.
Anticancer Res. 23:1509/1516, 2003
PubMed Abstract
VARADARAJAN S.-SHAH D.-DANDE P.-SETTLES S.-CHEN F.-FRONZA G.-GOLD B. DNA damage and cytotoxicity induced by minor groove binding methyl sulfonate esters.
Biochemistry 42:14318/14327, 2003
PubMed Abstract
VECCHIO D.-SASCO A.-CANN C.
Occupational risk in health care and research.
Am. J. Ind. Med. 43:369/397, 2003
PubMed Abstract
VENESIO T.-BALSAMO A.-RONDO M.-VARESCO L.-RISIO M.-RANZANI G.
APC haploinsufficiency, but not CTNNB1 or CDH1 gene mutations, accounts for a fraction of familial adenomatous polyposis patients without APC truncating mutations.
Lab. Invest. 83:1859/1866, 2003
PubMed Abstract
VENTURINI M.-DURANDO A.-GARRONE O.-COLOZZA M.-CONTU A.-STEVANI I.-GENTA F.-BIGHIN C.-LAMBIASE A.- DEL MASTRO L.
Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.
Cancer 97:1174/1180, 2003
PubMed Abstract
VIALE M.-MINETTI S.-OTTONE M.-LERZA R.-PARODI B.-PANNACCIULLI I.
Preclinical in vitro evaluation of hematotoxicity of the cisplatin procaine complex DPR.
Anticancer Drugs 14:163/166, 2003
PubMed Abstract
VINEIS P.-MILIGI L.-CROSIGNANI P.-DAVICO L.-FONTANA A.-MASALA G.-NANNI O.-RAMAZZOTTI V.- RODELLA S.-STAGNARO E.-TUMINO R.-VIGANO' C.-VINDIGNI C.-COSTANTINI A.
Delayed infection, late tonsillectomy or adenoidectomy and adult leukaemia: a case control study.
Br. J. Cancer 88:47/49, 2003
PubMed Abstract
VOGEL W.-BERNDT A.-MULLER A.-DAHSE R.-HAAS K.-BORSI L.-ZARDI L.-KOSMEHL H.
Differential in vivo and in vitro expression of ED-B+ fibronectin in adult human hematopoiesis.
Int. J. Mol. Med. 12:831/837, 2003
PubMed Abstract
ZAMBELLO R.-FALCO M.-DELLA CHIESA M.-TRENTIN L.-CAROLLO D.-CASTRICONI R.-CANNAS G.-CARLOMAGNO S.- CABRELLE A.-LAMY T.-AGOSTINI C.-MORETTA A.-SEMENZATO G.-VITALE M.
Expression and function of KIR and natural cytotoxicity receptors in NK type lymphoproliferative diseases of granular lymphocytes.
Blood 102:1797/1805, 2003
PubMed Abstract
ZANIBONI A.-ARDIZZONI A.-DE MARINIS F.-PORTALONE L.-BONI C.-MERIGGI F.-CAFFERATA M.-ARIGANELLO O.- TORRI V.-NEUMAIER C.-ROSSO R.
Phase II study of taxol combined with ifosfamide and carboplatin in the treatment of stage IIIb/IV non small cell lung cancer.
Am. J. Clin. Oncol. 26:84/88, 2003
PubMed Abstract
ZUCCOTTI S.-ROSANO C.-MANGIONE P.-BELLOTTI V.-BOLOGNESI M.
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly.
Acta Crystallogr. D Biol. Crystallogr. 59:1270/1272, 2003
PubMed Abstract
ZYLICZ Z.-KRAJNIK M.-VAN SORGE A.-COSTANTINI M.
Paroxetine in the treatment of severe non dermatological pruritus: a randomized, controlled trial.
J. Pain Symptom Manage. 26:1105/1112, 2003
PubMed Abstract

Riviste censite solo da Index Medicus


CANDIANI S.-KRESLOVA J.-BENES V.-OLIVERI D.-CASTAGNOLA P.-PESTARINO M.-KOZMIK Z.
Cloning and developmental expression of amphioxus Dachschund.
Gene Expr. Patt. 3:65/69, 2003
PubMed Abstract
FALUGI C.-TROMBINO S.-GRANONE P.-MARGARITORA S.-RUSSO P.
Increasing complexity of farnesyltransferase inhibitors activity: role in chromosome instability.
Curr. Cancer Drug Targets 3:109/118, 2003
PubMed Abstract
FRANCHINI M.-BALDI R.-GRIDELLI P.-PARODI S.-NERI R.-PALMIERI F.-PUNTONI R.- RICCO U.-FONTANA V.
Inquinamento da piombo ed effetti ematologici nel comune di La Spezia.
Epidemiol. Prev. 27:33/39, 2003
PubMed Abstract
GENNARO V.-CEPPI M.-MONTANARO F.
Rianalisi della mortalita' tra i lavoratori di un petrolchimico per la produzione di cloruro di vinile monomero (CVM) e policloruro di vinile (PVC).
Epidemiol. Prev. 27:221/225, 2003
PubMed Abstract
GENNARO V.-MONTANARO F.
Mesothelioma as marker of both exposures and effects.
Monaldi Arch. Chest Dis. 59:101/102, 2003
PubMed Abstract
GENNARO V.-PARODI S.-CEPPI M.-MONTANARO F.
Cancro nelle raffinerie di petrolio: assenza di rischio o misclassificazione? Letter.
Epidemiol. Prev. 27:173, 2003
PubMed Abstract
MERLO F.-BERTAZZI P.-BOLOGNESI C.-COLOMBI A.-FUSTINONI S.-BURATTI M.-FARMER P.-GARTE S.-LEVY L.- PESATORI A.-POPOV T.-TAIOLI E.-VALERIO F.-CONSONNI D.
Studio trasversale multicentrico europeo su esposizione a basse dosi di benzene.
G. Ital. Med. Lav. Ergon. 25:296/297, 2003
PubMed Abstract
NESTI M.-MARINACCIO A.-CHELLINI E.-Centri Operativi Regionali-GENNARO V.-MONTANARO F.- LAZZAROTTO A.-BIANCHELLI M.-CELESIA M.
La sorveglianza dei casi di mesotelioma maligno e la definizione delle esposizioni ad amianto: i dati ReNaM 1997.
Epidemiol. Prev. 27:147/153, 2003
PubMed Abstract

|  Web Team   |   Webmaster   |   Copyright © 2002-2010 IST   |   Disclaimer   |   Ultimo aggiornamento: 26/01/2010  |